BioGaia

117.60 SEK

-1.59 %

Less than 1K followers

BIOG B

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

-1.59 %
+5.00 %
+4.16 %
+10.73 %
+11.89 %
+15.41 %
+26.93 %
+43.94 %
+1,555.57 %

BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.

Read more
Market cap
11.9B SEK
Turnover
12.52M SEK
Revenue
1.54B
EBIT %
26.82 %
P/E
35.74
Dividend yield-%
3.4 %
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
7/5
2026

General meeting '26

7/5
2026

Interim report Q1'26

8/5
2026

Bonus dividend

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.